Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2022 Earnings Conference Call February 9, 2023 4:30 PM ET
Company Participants
Kim Golodetz - Lippert/Heilshorn & Associates
Joseph Sardano - Co-Founder, Chairman & CEO
Michael Sardano - President & General Counsel
Javier Rampolla - CFO
Conference Call Participants
Benjamin Haynor - Alliance Global Partners
Alexander Nowak - Craig-Hallum
Scott Henry - ROTH MKM Partners
Anthony Vendetti - Maxim Group
Operator
Welcome to the Sensus Healthcare Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions].
Please also note that this event is being recorded today. I would now like to turn the conference over to Kim Golodetz with LHA Investor Relations. Please go ahead.
Kim Golodetz
Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel; and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address activities Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future are forward-looking statements. The forward-looking statements are management's beliefs based on currently available information as of the date of this conference call, February 9, 2023. Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements except as required by law. All forward-looking statements are subject to risks and uncertainties as described in the company's Forms 10-K and 10-Q.
During today's conference call, references will be made to certain non-GAAP financial measures. Sensus believes these measures provide useful information for investors yet they should not be considered as a substitute for GAAP nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today's financial results press release.
With that said, I'd like to turn the call over to Joe Sardano. Joe?
Joseph Sardano
Thank you, Kim, and good afternoon, everyone. I address you today with the highest of confidence that Sensus Healthcare is better positioned today than ever before in our history with all the pieces in place for even greater execution of our business plan. We believe our superficial radiation therapy technology remains the #1 choice for noninvasive treatment of skin cancer by both physicians and patients. Our improved reimbursement, combined with our fair market value lease program, provides our customers with an excellent patient acquisition tool, making the acquisition of our lead technology and easy transplant.